Company / Current Liabilities
NovoCure Ltd Current Liabilities History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$223.2M
FY2025
5-year range
$142.6M / $756.4M
FY2021-FY2025
Trend
-70.5%
vs FY2024
Sector context
#101 of 165
Health Care
What the data says
At $223M, NovoCure Ltd's current liabilities ranks #65 of 165 in the Health Care sector. Increased from $179M to $223M over the past 2 years.
Based on SEC 10-K filings.
$223M in FY2025 with a 5-year CAGR of +14.5%.
Increased from $179M to $223M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +12.0%
- 5-Year CAGR
- +14.5%
- 10-Year CAGR
- -
Sector benchmark
#65 of 165 in Health CareTop 39% of 165This company $223.2M Sector average $4.4B
▼
-94.9% below sector average
Key checks
Key Insights
- 5-year CAGR of +14.5%, indicating consistent growth.
- In FY2025, current liabilities decreased 70.5% year-over-year.
- Ranks #101 out of 165 companies in the Health Care sector.
- Peak current liabilities was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score -0.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $223.2M | -70.5% |
| FY2024 | $756.4M | +322.3% |
| FY2023 | $179.1M | +12.8% |
| FY2022 | $158.8M | +11.3% |
| FY2021 | $142.6M | +25.5% |
| FY2020 | $113.6M | +31.6% |
| FY2019 | $86.3M | +33.7% |
| FY2018 | $64.6M | +28.6% |
| FY2017 | $50.2M | +36.1% |
| FY2016 | $36.9M | +28.8% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026